These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 3538789)

  • 81. [Clinical analysis of cerebral vasospasm following subarachnoid hemorrhage. Part 1 Sequential changes of incidence and degree and its clinical significance (author's transl)].
    Koike T; Ishii R; Kameyama S; Ihara I; Takeuchi S; Kobayashi K
    Neurol Med Chir (Tokyo); 1979 Aug; 19(8):793-800. PubMed ID: 91133
    [No Abstract]   [Full Text] [Related]  

  • 82. Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage.
    Hongo K; Kobayashi S
    Neurol Res; 1993 Aug; 15(4):218-24. PubMed ID: 8105400
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment of symptomatic vasospasm with nimodipine.
    Dorsch NW; Compton JS
    Ann Acad Med Singap; 1993 May; 22(3 Suppl):407-9. PubMed ID: 8215189
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Calcium antagonists and aneurysmal subarachnoid haemorrhage.
    Lancet; 1983 Jul; 2(8342):141-3. PubMed ID: 6134985
    [No Abstract]   [Full Text] [Related]  

  • 85. [Cerebral vasospasm after subarachnoid hemorrhage. Current possibilities of prevention and treatment].
    Stachura K; Danilewicz B
    Przegl Lek; 2002; 59(1):46-8. PubMed ID: 12108047
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations.
    Fisher CM; Roberson GH; Ojemann RG
    Neurosurgery; 1977; 1(3):245-8. PubMed ID: 615969
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis.
    Barker FG; Ogilvy CS
    J Neurosurg; 1996 Mar; 84(3):405-14. PubMed ID: 8609551
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Pharmacological treatment of vasospasm in subarachnoid hemorrhage].
    Melon E; Rimaniol JM
    Ann Fr Anesth Reanim; 1996; 15(3):366-73. PubMed ID: 8758597
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Use of calcium inhibitors in subarachnoid hemorrhage].
    Guggiari M
    Agressologie; 1989 Jun; 30(7):407. PubMed ID: 2817236
    [No Abstract]   [Full Text] [Related]  

  • 91. The relationship between timing of surgery and operative complications in aneurysmal subarachnoid hemorrhage.
    Tucker WS
    Can J Neurol Sci; 1987 Feb; 14(1):84-7. PubMed ID: 3545414
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reference: nimodipine in cerebral vasospasm.
    Dorsch NW; Little JM
    Neurosurgery; 1989 Jun; 24(6):959-60. PubMed ID: 2664549
    [No Abstract]   [Full Text] [Related]  

  • 93. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage.
    Levesque H; Sevrain L; Freger P; Tadie M; Courtois H; Creissard P
    Lancet; 1990 Feb; 335(8684):290. PubMed ID: 1967742
    [No Abstract]   [Full Text] [Related]  

  • 94. Cerebral vasospasm associated with subarachnoid hemorrhage due to ruptured intracranial aneurysm.
    Millikan CH
    Trans Am Neurol Assoc; 1974; 99():1-23. PubMed ID: 4463518
    [No Abstract]   [Full Text] [Related]  

  • 95. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Correlation between angiographic vasospasm, hematoma, and ischemic brain damage following SAH.
    Graham DI; Macpherson P; Pitts LH
    J Neurosurg; 1983 Aug; 59(2):223-30. PubMed ID: 6864287
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study.
    Solenski NJ; Haley EC; Kassell NF; Kongable G; Germanson T; Truskowski L; Torner JC
    Crit Care Med; 1995 Jun; 23(6):1007-17. PubMed ID: 7774210
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Symptomatic cerebral vasospasm manifested 18 days after aneurysmal subarachnoid haemorrhage.
    Kawamata T; Aoki N; Sakai T; Arai K
    Neurol Res; 1993 Jun; 15(3):209-11. PubMed ID: 7690121
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Traumatic subarachnoid haemorrhage.
    Patel HC; Hutchinson PJ; Pickard JD
    Hosp Med; 1999 Jul; 60(7):497-9. PubMed ID: 10605541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.